As described in the American Pain Foundation/CenterWatch Clinical Trial Database under
Clinical Trials: Fibromyalgia:
We are currently inviting chronic pain patients to participate in a study to investigate a treatment for pain that uses newly developed brain imaging methods to train participants to control their own brain activation.
All participants in this study will receive a new form of cognitive training for controlling pain.
A central goal of the study is to measure the impact of a new form of cognitive strategies for pain control on activations from brain regions involved in the experience of pain.
Participants will be scanned using functional MRI while they employ cognitive strategies allowing the participant to view their brain activity.
Some participants will see their own brain activation during this process while other participants will see very similar but simulated data that does not come from their brain.
Study inclusion / exclusion criteria
Men and Women, ages 18-55 years
Clinically diagnosed chronic pain. Some example diagnoses include: CRPS, RSD, neuropathy, neuralgia, fibromyalgia, or migraine.
No implanted medical devices that are not compatible with MRI (spinal cord stimulator/pump, pacemaker, surgical aneurysm clip, etc)
No recent history of severe psychiatric illness
Weight less than 220 lbs.
Able to be scanned in MRI without claustrophobia
No facial tattoos, non-removable metal implants, piercings, or extensive dental work.
Not pregnant or having fertility treatments
Able to read and understand English
Additional screening criteria for MRI safety may be required
Procedure
This is an experimental procedure and a controlled trial. We cannot and do not imply that this study will lead to a decrease in your pain.
Location
Participants must be able to attend sessions in Menlo Park, CA. We reimburse for travel time within the Bay Area.
Compensation
In addition to extensive interaction with our knowledgeable research team, eligible participants will receive cash compensation for their participation (i.e. travel time, questionnaires, and all time in scanner).
Sponsor
The Principal Investigator on this research study is Dr. Christopher deCharms, PhD. This study is sponsored by Omneuron, Inc. and receives funding from the National Institutes of Health.
If you would like to learn more about prticipating in this study, you may fill out an e-mail message form at the bottom of the trial listing.
And/or Contact:
Ella Laramee
Omneuron, Inc.
99 El Camino Real
Menlo Park, CA 94025
Telephone: 650-585-5304
E-mail: elaramee@omneuron.com
